Pensée Wu1, Randula Haththotuwa2, Chun Shing Kwok1, Aswin Babu1, Rafail A Kotronias1, Claire Rushton1, Azfar Zaman1, Anthony A Fryer1, Umesh Kadam1, Carolyn A Chew-Graham1, Mamas A Mamas1. 1. From the Institute for Science and Technology in Medicine (P.W.), Keele Cardiovascular Research Group (P.W., C.S.K., A.B., R.A.K., C.R., U.K., M.A.M.), Institute for Primary Care and Health Sciences (R.H., C.A.C.-G.), Institute for Applied Clinical Sciences (A.A.F., C.S.K., C.R., U.K., M.A.M.), and NIHR Collaboration for Leadership in Applied Health Research and Care (CLAHRC) West Midlands (C.A.C.-G.), Keele University, Stoke-on-Trent, United Kingdom; Academic Obstetrics and Gynaecology (P.W.) and The Heart Centre (C.S.K., M.A.M.), Royal Stoke University Hospital, Stoke-on-Trent, United Kingdom; and Freeman Hospital and Institute of Cellular Medicine, Newcastle University, Newcastle-Upon-Tyne, United Kingdom (A.Z.). 2. From the Institute for Science and Technology in Medicine (P.W.), Keele Cardiovascular Research Group (P.W., C.S.K., A.B., R.A.K., C.R., U.K., M.A.M.), Institute for Primary Care and Health Sciences (R.H., C.A.C.-G.), Institute for Applied Clinical Sciences (A.A.F., C.S.K., C.R., U.K., M.A.M.), and NIHR Collaboration for Leadership in Applied Health Research and Care (CLAHRC) West Midlands (C.A.C.-G.), Keele University, Stoke-on-Trent, United Kingdom; Academic Obstetrics and Gynaecology (P.W.) and The Heart Centre (C.S.K., M.A.M.), Royal Stoke University Hospital, Stoke-on-Trent, United Kingdom; and Freeman Hospital and Institute of Cellular Medicine, Newcastle University, Newcastle-Upon-Tyne, United Kingdom (A.Z.). randula@doctors.org.uk.
Abstract
BACKGROUND: Preeclampsia is a pregnancy-specific disorder resulting in hypertension and multiorgan dysfunction. There is growing evidence that these effects persist after pregnancy. We aimed to systematically evaluate and quantify the evidence on the relationship between preeclampsia and the future risk of cardiovascular diseases. METHODS AND RESULTS: We studied the future risk of heart failure, coronary heart disease, composite cardiovascular disease, death because of coronary heart or cardiovascular disease, stroke, and stroke death after preeclampsia. A systematic search of MEDLINE and EMBASE was performed to identify relevant studies. We used random-effects meta-analysis to determine the risk. Twenty-two studies were identified with >6.4 million women including >258 000 women with preeclampsia. Meta-analysis of studies that adjusted for potential confounders demonstrated that preeclampsia was independently associated with an increased risk of future heart failure (risk ratio [RR], 4.19; 95% confidence interval [CI], 2.09-8.38), coronary heart disease (RR, 2.50; 95% CI, 1.43-4.37), cardiovascular disease death (RR, 2.21; 95% CI, 1.83-2.66), and stroke (RR, 1.81; 95% CI, 1.29-2.55). Sensitivity analyses showed that preeclampsia continued to be associated with an increased risk of future coronary heart disease, heart failure, and stroke after adjusting for age (RR, 3.89; 95% CI, 1.83-8.26), body mass index (RR, 3.16; 95% CI, 1.41-7.07), and diabetes mellitus (RR, 4.19; 95% CI, 2.09-8.38). CONCLUSIONS: Preeclampsia is associated with a 4-fold increase in future incident heart failure and a 2-fold increased risk in coronary heart disease, stroke, and death because of coronary heart or cardiovascular disease. Our study highlights the importance of lifelong monitoring of cardiovascular risk factors in women with a history of preeclampsia.
BACKGROUND: Preeclampsia is a pregnancy-specific disorder resulting in hypertension and multiorgan dysfunction. There is growing evidence that these effects persist after pregnancy. We aimed to systematically evaluate and quantify the evidence on the relationship between preeclampsia and the future risk of cardiovascular diseases. METHODS AND RESULTS: We studied the future risk of heart failure, coronary heart disease, composite cardiovascular disease, death because of coronary heart or cardiovascular disease, stroke, and stroke death after preeclampsia. A systematic search of MEDLINE and EMBASE was performed to identify relevant studies. We used random-effects meta-analysis to determine the risk. Twenty-two studies were identified with >6.4 million women including >258 000 women with preeclampsia. Meta-analysis of studies that adjusted for potential confounders demonstrated that preeclampsia was independently associated with an increased risk of future heart failure (risk ratio [RR], 4.19; 95% confidence interval [CI], 2.09-8.38), coronary heart disease (RR, 2.50; 95% CI, 1.43-4.37), cardiovascular disease death (RR, 2.21; 95% CI, 1.83-2.66), and stroke (RR, 1.81; 95% CI, 1.29-2.55). Sensitivity analyses showed that preeclampsia continued to be associated with an increased risk of future coronary heart disease, heart failure, and stroke after adjusting for age (RR, 3.89; 95% CI, 1.83-8.26), body mass index (RR, 3.16; 95% CI, 1.41-7.07), and diabetes mellitus (RR, 4.19; 95% CI, 2.09-8.38). CONCLUSIONS: Preeclampsia is associated with a 4-fold increase in future incident heart failure and a 2-fold increased risk in coronary heart disease, stroke, and death because of coronary heart or cardiovascular disease. Our study highlights the importance of lifelong monitoring of cardiovascular risk factors in women with a history of preeclampsia.
Authors: Krishna G Aragam; Amanda Dobbyn; Renae Judy; Mark Chaffin; Kumardeep Chaudhary; George Hindy; Andrew Cagan; Phoebe Finneran; Lu-Chen Weng; Ruth J F Loos; Girish Nadkarni; Judy H Cho; Rachel L Kember; Aris Baras; Jeffrey Reid; John Overton; Anthony Philippakis; Patrick T Ellinor; Scott T Weiss; Daniel J Rader; Steven A Lubitz; Jordan W Smoller; Elizabeth W Karlson; Amit V Khera; Sekar Kathiresan; Ron Do; Scott M Damrauer; Pradeep Natarajan Journal: J Am Coll Cardiol Date: 2020-06-09 Impact factor: 24.094
Authors: Lisa D Levine; Jennifer Lewey; Nathanael Koelper; Katheryne L Downes; Zolt Arany; Michal A Elovitz; Mary D Sammel; Bonnie Ky Journal: Pregnancy Hypertens Date: 2019-05-30 Impact factor: 2.899
Authors: Michael C Honigberg; Hilde Kristin Refvik Riise; Anne Kjersti Daltveit; Grethe S Tell; Gerhard Sulo; Jannicke Igland; Kari Klungsøyr; Nandita S Scott; Malissa J Wood; Pradeep Natarajan; Janet W Rich-Edwards Journal: Hypertension Date: 2020-08-24 Impact factor: 10.190